At Chambograft, our technology merges biology and innovation to redefine what’s possible in bone regeneration. By combining conventional bone allografts with amniotic and chorionic membranes, we create a powerful, biocompatible solution that enhances healing, reduces inflammation, and minimizes rejection—without the need for anti-rejection drugs. This hybrid approach not only preserves structural integrity but also harnesses the natural growth factors found in birth-derived tissues, setting a new standard in regenerative grafting. .
Bone Allograft Foundation
Our process starts with high-quality donor bone, processed to preserve its structural and biological properties. Bone allografts serve as the essential framework—supporting osteoconduction, promoting cellular attachment, and ensuring mechanical strength during surgery and recovery.
Amniotic & Chorionic Layers
We integrate decellularized amniotic and chorionic membranes—rich in natural cytokines and growth factors. These biological layers have shown exceptional potential in reducing inflammation, stimulating regeneration, and supporting cellular migration in damaged tissues.
Low Rejection, High Compatibility
Thanks to decellularization, our grafts maintain regenerative signals while minimizing immune triggers. This means no immunosuppressive drugs, faster recovery, and dramatically improved patient outcomes in both orthopedic and soft tissue applications.
Surgical Efficiency
Chambograft products are designed for real-world surgical use. They are easy to handle, moldable when hydrated, and structurally stable—ensuring precision, confidence, and consistency in every procedure.